The US federal government has requested the dismissal of pending criminal charges against former Taro Pharmaceutical executive Ara Aprahamian, who more than three years ago was accused of generic price-fixing and allocation of customers, in the latest development in the US’s sprawling generic price-fixing saga.
“Dismissal of this case is not contrary to manifest public interest, and it will allow the conservation of this court’s time and resources,” US prosecutors stated in their unopposed motion to dismiss the indictment,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
